ArticleApplied health economics and health policy2021

Cost-Effectiveness of Bosutinib for the Treatment of Adult Patients with Chronic Phase Chronic Myeloid Leukemia in the Second-Line Setting.

B Muresan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.